Alligator Bioscience
0.265
SEK
-0.75 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
-0.75%
-49.81%
-79.99%
-77.39%
-61.61%
-62.85%
-81.19%
-95.12%
-98.7%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
201.15M SEK
Turnover
487.73K SEK
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Financial calendar
13.2
2025
Annual report '24
24.4
2025
Interim report Q1'25
ShowingAll content types
Last day of trading in warrants series TO 9 in Alligator Bioscience AB is 13 December 2024
Alligator Bioscience: BioStock: Alligator's CEO: "We are on track to secure a partnership"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools